Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Invesco Perpetual High Income

Ranked 89 out of 109 in - UK Equity Income over 12 months
All calculations are in GBP unless stated

Managed by

Mark Barnett

Based in Henley-on-Thames, Mark Barnett is responsible for the management of a number of UK equity portfolios, with a focus on the management of open and closed ended vehicles. Mark began his investment career with Mercury Asset Management in 1992. Mark joined Invesco Perpetual in 1996. Since then, he has become one of the team¡¯s most experienced fund managers, specialising in UK equity income investing. He graduated in French and Politics from Reading University in 1992 and has passed the associate examinations of the Association for Investment Management and Research (AIMR).

Objective

The fund aims to achieve a high level of income, together with capital growth. The fund intends to invest primarily in companies listed in the UK, with the balance invested internationally. In pursuing this objective, the fund managers may include investments that they consider appropriate which include transferable securities, money market instruments, warrants, collective investment schemes, deposits and other permitted investments and transactions.

Showing fund performance in United Kingdom View performance globally

Performance

UK Equity Income over : 31/03/2016 - 31/03/2017

Total Return

Quarterly Performance

to 31/03/2017 Annual Q1 Q2 Q3 Q4
2017 3.1%
2016 3.2% -3.6% 0.3% 4.6% 2.1%
2015 9.7% 6.8% -1.6% -0.5% 4.9%
2014 10.1% 2.6% 2.8% 1.4% 2.9%
2013 26.0% 14.8% 1.9% 3.1% 4.5%
2012 8.1% 3.6% 0.8% 4.0% -0.5%
2011 9.5% 1.5% 4.4% -3.7% 7.3%
2010 11.4% 3.7% -5.0% 8.6% 4.0%
2009 10.4% -12.6% 6.7% 13.4% 4.4%
2008 -19.1% -12.8% -1.6% -5.9% 0.2%
2007 7.4% 3.1% 3.6% -1.6% 2.3%
2006 27.7% 7.6% 0.1% 9.9% 7.9%
2005 27.5% 3.7% 6.8% 6.8% 7.8%
2004 22.1% 4.7% 4.8% -0.1% 11.4%
2003 23.4% -8.2% 21.6% 1.3% 9.2%
2002 -10.3% 11.3% -6.8% -12.9% -0.7%
2001 1.9% -2.4% 6.0% -14.5% 15.2%
2000 18.2% -4.3% 8.3% 2.2% 11.7%
1999 10.6% 10.3% 4.5% -5.1% 1.1%
1998 10.3% 16.4% -1.4% -17.0% 15.8%
1997 28.8% 5.9% 7.4% 11.2% 1.9%
1996 16.0% 1.7% 1.6% 4.9% 7.0%
1995 4.6%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

31/01/2017

Top 10 Holdings

Stock Size
Reynolds American Inc ORD 7.09
BP PLC ORD 4.95
British American Tobacco PLC ORD 4.65
AstraZeneca PLC ORD 3.59
Legal & General Group PLC ORD 3.38
Provident Financial PLC ORD 3.26
Imperial Brands PLC ORD 3.24
BAE Systems PLC ORD 2.90
BT Group PLC ORD 2.54
Roche Holding AG Par 2.21
31/01/2017

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date08/02/1988
  • Share Class size11,166Mn
  • Base currencyGBP
  • ISIN GB0033054015

Purchase Info

  • Min. initial investment500
  • Min. regular additional investment0

Charges

  • Initial investment5

Related News

Invesco's Barnett cuts stake in troubled Allied Minds

Invesco Perpetual's Mark Barnett has reduced his position in Allied Minds, following a $147 million writedown announced on Wednesday.

Old Mutual hits FTSE as South African minister sacked

Stocks with exposure to South Africa slump after president Jacob Zuma sacks respected finance minister Pravin Gordhan.

FTSE clings to all-time highs despite Capita slump

FTSE steadies at all-time highs despite slump in Capita shares as outsourcing group misses profit target and announces chief executive's resignation.

HL equity income study: the top 10 credit crunch stars

A study from Hargreaves Lansdown shines a light on the top 10 equity income funds over the last 10 years.

Sweet 16: good value investment trust winners!

Analysts at Canaccord Genuity identify 16 investment trusts with lower charges and better performance than equivalent open-ended funds. 

Woodford and Barnett take £200m hit on Capita crash

Star fund managers see Capita stakes lose quarter of their value as outsourcing group issues shock profit warning.

Woodford and Barnett drug stock dives 65% on test failure

Circassia Pharmaceuticals shares plummet after cat allergy treatment fails trial, dealing blow to backers Neil Woodford and Mark Barnett.

Woodford IM restructures after explosive growth

Neil Woodford's fund management group has applied to switch structure after strong growth of the business.

Odey's Swan flies as equity short pays off explosively

A year-to-date return of 15.4% represents a U-turn on the 12.7% loss in 2015, though ongoing volatility remains a potent threat.

Is Woodford biting off more than he can chew?

As Neil Woodford eyes more funds for his Patient Capital investment trust, we take an in-depth look at his record of 'early stage' investing.

...more...

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).